Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...

According to a new study published in Psychedelics, the answer ranges from 2.2 to 5.6 million people currently being treated ...

AI and psychedelic medicine are merging, with research showing AI's role in drug discovery, trials, and personalized mental ...

Introduction In recent years, psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, has garnered ...

Trippy: The Peril and Promise of Medicinal Psychedelics” looks at both the Indigenous use and modern research behind psychoactive substances.

Psychedelic-assisted therapy is a combined method that uses psychotherapy and pharmacotherapy with the help of psychedelics ...

A recent study published in the Journal of Affective Disorders suggests that a single dose of psilocybin may offer hope for U ...

has created software they hope will become the de facto system for providers of psychedelic-assisted therapy in Colorado and ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

How can benefits from psychedelics be expanded despite the rejection of Question 4? And should the legislature try to reverse ...

Compass Pathways is advancing pivotal trials to test psilocybin's impact on treatment-resistant depression. See why I rate ...